US Senator Klobuchar enters bills banning pay-for-delays, sham litigation in drug markets
MLex Summary: US Senator Amy Klobuchar has introduced two bills to sanction conduct in drug markets, one that would prohibit so-called "pay-for-delay" schemes, in which a brand name drug or biological...To view the full article, register now.
Already a subscriber? Click here to view full article